SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANSERVIGI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.789
EU - Europa 1.887
AS - Asia 1.153
OC - Oceania 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 9.847
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.784
CN - Cina 805
UA - Ucraina 578
GB - Regno Unito 336
TR - Turchia 307
DE - Germania 266
IT - Italia 196
SE - Svezia 139
PL - Polonia 133
FI - Finlandia 116
BE - Belgio 32
FR - Francia 32
AT - Austria 28
IR - Iran 14
KR - Corea 7
RU - Federazione Russa 7
IN - India 6
NL - Olanda 6
BR - Brasile 5
CA - Canada 5
ES - Italia 4
NZ - Nuova Zelanda 4
RO - Romania 4
VN - Vietnam 4
EU - Europa 3
HK - Hong Kong 3
AU - Australia 2
BG - Bulgaria 2
DK - Danimarca 2
LI - Liechtenstein 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
MA - Marocco 1
MD - Moldavia 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
Totale 9.847
Salva come PNG Salva come JPEG
Città #
Woodbridge 891
Fairfield 841
Jacksonville 619
Houston 590
Chandler 504
Ann Arbor 458
Ashburn 404
Wilmington 331
Seattle 328
Cambridge 282
Nanjing 194
Beijing 193
Izmir 188
New York 142
Princeton 134
Warsaw 133
San Diego 87
Boardman 59
Shenyang 58
Milan 51
Nanchang 47
Shanghai 41
Hebei 38
Tianjin 38
Jiaxing 37
San Mateo 34
Brussels 32
Ferrara 30
Vienna 28
Changsha 26
Jinan 23
Ningbo 23
Norwalk 20
Falls Church 19
Washington 18
Mountain View 17
Philadelphia 16
Dearborn 15
Kunming 15
Leawood 15
Auburn Hills 14
Augusta 14
Orange 12
Guangzhou 11
Redwood City 11
Taizhou 11
Zhengzhou 11
Ardabil 10
London 10
Verona 10
Los Angeles 9
Monmouth Junction 8
Des Moines 7
Indiana 7
Bologna 6
Bremen 6
Hangzhou 6
Addison 5
Haikou 5
Helsinki 5
Lanzhou 5
Changchun 4
Rome 4
Acton 3
Auckland 3
Bari 3
Chicago 3
Dong Ket 3
Napoli 3
Pieve Emanuele 3
Wandsworth 3
Amsterdam 2
Düsseldorf 2
Genoa 2
Hong Kong 2
Hounslow 2
Madrid 2
Paris 2
Pune 2
Roseto Degli Abruzzi 2
Sofia 2
Taiyuan 2
Tappahannock 2
Toronto 2
Valeggio sul Mincio 2
Vanzago 2
Alcalá De Henares 1
Allahabad 1
Andover 1
Angus 1
Aprilia 1
Bangalore 1
Belgrade 1
Brookline 1
Brugg 1
Buffalo 1
Büdelsdorf 1
Cairo 1
Capannori 1
Castelfranco Emilia 1
Totale 7.278
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 188
null 179
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 149
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 135
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 131
Herpes Simplex Virus Growth, Preparation, and Assay 125
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 122
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 121
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 120
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 119
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 119
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 118
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 117
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 114
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 114
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 113
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 111
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 111
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 110
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 109
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 109
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 109
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 109
null 107
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 106
Replication-competent herpes simplex vectors: design and applications 105
null 104
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 104
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 104
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 104
null 104
Herpesvirus/retrovirus chimeric vectors 103
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 102
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 101
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 100
HSV as a vector in vaccine development and gene therapy 100
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 100
null 99
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 99
Purinergic Signaling: A New Pharmacological Target Against Viruses? 98
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 97
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 97
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 97
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 95
HSV as a vector in vaccine development and gene therapy 95
null 95
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 93
MEMBRANE PROTEIN PATTERN IN HEREDITARY SPHEROCYTOSIS IN FIVE SUBJECTS FROM NORTH-EAST ITALY OBTAINED BY SDS-PAGE USING N,N'-DIALLYLTARTARDIAMIDE 92
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 92
State of viral DNA in BK virus-transformed rabbit cells 91
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 90
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 90
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 90
null 89
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 88
null 88
null 88
HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) URACIL-DNA GLYCOSYLASE - FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI, BIOCHEMICAL-CHARACTERIZATION, AND SELECTIVE-INHIBITION BY 6-(P-N-OCTYLANILINO)URACIL 86
HSV-1 virions engineered for specific binding to cell surface receptors 84
null 83
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 83
Virus erpetici come vettori vaccinali 82
null 81
null 80
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 80
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 80
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 79
Capitolo 55 Retrovirus 79
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 78
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 77
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 76
Molecular diagnosis of herpes simplex encephalitis 73
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 70
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 70
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 69
CELL-TYPE DEPENDENT SENSITIVITY OF HERPES-SIMPLEX-VIRUS-1 MUTANTS TO PLAQUE DEVELOPMENT INHIBITION BY AN ANTI-GD MONOCLONAL-ANTIBODY 67
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 63
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 63
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 62
Niosomes containing HSV immunogens as possible vaccine against genital herpes 62
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 60
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 60
Constitutive expression in human cells of herpes simplex type 1 glycoprotein B gene cloned in an episomal eukaryotic vector 59
Transformation by defined regions of herpes simplex virus DNA. 59
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 59
Capitolo 44 Herpesviridae 58
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 58
Intranasal immunization with non-ionic surfactant vescicles containing a secreted recombinant form of gB protein confers protective immunity against genital herpes in mice 57
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 57
Ocular disease patterns caused by genetically related mutants of Herpes simplex virus type 1. 57
The expression of immediate early genes of herpes simplex virus type 1 contributes to the neuroplasticity induced by viral infection on the enteric nervous system 56
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 55
Niosomes for vaginal administration of an antiherpetic peptide 55
Gene therapy of the nervous system by herpes virus vectors 55
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 54
Molecular analysis of behavior by gene transfer into neurons with herpes simplex vectors 53
Sequences homologous to two separate transforming regions of herpes simplex virus DNA are linked in two genital tumors 53
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 53
Virus vectors for immunoprophylaxis 52
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 52
Totale 9.008
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.943
Totale 34.964
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.039 0 0 0 0 0 0 0 0 0 234 267 538
2019/20202.301 401 79 94 327 142 232 180 244 148 238 176 40
2020/20211.461 136 124 69 152 66 173 65 175 24 175 227 75
2021/20221.407 58 137 86 83 76 48 70 65 56 91 124 513
2022/20231.152 131 48 64 149 176 186 42 106 143 10 68 29
2023/2024534 68 78 29 24 60 180 38 39 15 3 0 0
Totale 9.941